RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose,
Established Protocol: Effective dose
Route of Administration:
Cannabinoid Ratio: (CBD) 0 
Dosage Form: Cannabidiol administered intraperitoneally
Dosing Regimen: Cannabidiol 30 mg/kg
Treatment Duration: 14 days
Citation:
